We’re thrilled to announce an exciting new partnership between HEMEX and YouEngineering, a software engineering company which aims to foster digital progress. Our latest partnership enables us to provide healthcare start-ups with a new range of digital packages to guarantee our clients the best results in mobile app, software development, and web design.
Investment Press Release
hemotune makes a significant step forward: advancing into clinical trials after completing CHF 14 million Series B2 round
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Diversity Hemex Team
We welcome David to the team!
HEMEX contribution for preparing tomorrow's leaders!
Continue reading
Investment Press Release
Driving the future of non-surgical endometriosis diagnosis: Hera Biotech acquires Scailyte’s endometriosis diagnostic assets
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Hemex Team
Graphic Design Internship at HEMEX
Noémie is a student at FMS Muttenz. She completed a two-week internship at HEMEX focusing [...]
Continue reading
Hemex Team Press Release
HEMEX opens subsidiary in Belgium, expanding its presence in the EU
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
HEMEX is delighted to announce an exciting new partnership with Avanti Europe. The
Avanti Europe team is a specialist consultancy and expert knowledge provider. This
partnership will allow us to complete the range of products we provide to healthcare start-ups to ensure we continue offering excellent support within the life science industry.
Innovation, Press Release
InQbator: New startup incubator & accelerator powered by BLKB, HEMEX & Launchpad
BLKB, HEMEX and Launchpad aim to support young entrepreneurs in their business activities through the start-up incubator program, inQbator. The program is open to start-ups from all industries. The main aim of inQbator is to promote innovation in the region.
We are thrilled to announce the successful completion of an oversubscribed Series C to further accelerate our company’s growth.
HEMEX is delighted to announce our exciting new partnership with SMART-TRIAL. Collecting and managing clinical data has been revolutionized for the MedTech industry and we are pleased that eCRF, eConsent, and more can now be done with confidence. This partnership enables us to provide healthcare start-ups with a complete range of packages to ensure conducting clinical trials, PMCF studies, and monitoring is made easy and affordable.
Our portfolio company Opterion Health AG announced today the successful agreement of a EUR 8.4m Bridge Financing
Round. The proceeds from this financing round will be used to complete preclinical activities and prepare for entry into Phase I. Heartfelt congratulations on your success, Opterion!
Press Release
ASPIVIX Reports Positive First-In-Women Results Using Novel Suction-Based Cervical Device in IUD Procedures
Our portfolio company ASPIVIX SA announced last week the completion of and interim analysis results from its Phase I first-in-women trial. The two-phase ADVANCE Women trial is assessing the usability, efficacy, and safety of the investigational CAREVIX, the innovative device designed as a modern and gentler alternative. Warmest congratulations on your achievement, ASPIVIX!
HEMEX is delighted to announce our exciting new partnership with QualityKick. A compliant, cloud-based, and pre-validated solution for Quality Management in Life Sciences. This partnership enables us to provide healthcare start-ups with a complete range of packages to ensure no Quality Management System gets left behind.
